Following the landmark discovery in 1965 of the Australian antigen, subsequently renamed the hepatitis ... renal function. Pediatric carriers of chronic HBV often do not have overt liver disease ...

The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

It usually happens over a long period, often due to hepatitis, alcohol use disorder ... more of these conditions: Your liver disease can also lead to a kidney disease called hepatorenal syndrome ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type 2 diabetes and chronic kidney disease, the company said in a news release.